Paul Andrea

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Paul Andrea's trades of Zentalis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-05 2025-02-03
S Sale
13,559 -13.6%
359.26
US$2,684,802 		13,559 -13.6% 359.26 US$2,684,802
2025-02-03 2025-02-03
PrS Proposed sale
6,849
33.24
US$594,477 		6,849 33.24 US$594,477
2024-02-05 2024-02-02
S Sale
86,491 +40.2%
301.84
US$4,878,618 		86,491 +40.2% 301.84 US$4,878,618
2024-02-02 2024-02-02
PrS Proposed sale
3,310
11.54
US$38,189 		3,310 11.54 US$38,189